| Date | Title | Description |
| 09.04.2026 | Click Therapeutics Secures $50M to Commercialize Schizophrenia Digital Therapeutic | What You Should Know
Boehringer Ingelheim and Click Therapeutics have restructured their commercialization agreement for CT-155.
Boehringer is transferring all commercial and marketing rights to Click, backed by a $50M Series D strategic in... |
| 19.01.2026 | Your Ultrahuman smart ring now knows a migraine is coming before you do | Ultrahuman has just teamed up with Click Therapeutics to launch the Migraine PowerPlug, and honestly, this feels like a significant shift for smart wearables. It’s a new software feature for the Ultrahuman Ring Air that borrows technology f... |
| 16.01.2026 | This smart ring targets your daily triggers if you get migraines | Ultrahuman is bringing migraine support to its wearable ecosystem with Ultrahuman Migraine PowerPlug, a software feature inside the Ultrahuman app built with Click Therapeutics. The goal is to make your ring data useful when symptoms and tr... |
| 14.01.2026 | Ultrahuman and Click Therapeutics Launch World’s First Biomarker-Driven Migraine Tool | What You Should Know
– Ultrahuman, the global leader in wearable health technology, has partnered with Click Therapeutics to develop the Migraine PowerPlug. This first-of-its-kind tool integrates the proprietary technology behind Click’s CT... |
| 15.04.2025 | Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention | What You Should Know:
– Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has rece... |
| 22.05.2024 | Click Therapeutics Acquires Better Therapeutics, Expands into Obesity and Cardiometabolic Disease | What You Should Know:
– Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.
– Click’s expansion into cardiometabolic disease follows successful DTx... |
| 22.05.2024 | Click Therapeutics acquires Better Therapeutics assets | figcaption>span]:font-sans">
Click Therapeutics, a provider of prescription treatments via a smartphone, has acquired assets of Better Therapeutics.
Why it matters: Several companies have made early headway in the space only to s... |
| 15.04.2024 | Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million | - |
| 15.04.2024 | Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million | ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases... |
| 29.03.2024 | DarioHealth reports decreased revenue following Twill acquisition | Photo: JGI/Tom Grill/Blend Images/Getty Images
DarioHealth, a digital chronic-condition-management platform, reported $3.6 million in revenue for Q4 2023, compared to $6.8 million for the fourth quarter of 2022, a 47% decrease. Year-over-ye... |
| 18.03.2024 | Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million | - |
| 18.03.2024 | Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million | ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases... |
| 03.07.2023 | Pharma can’t let Big Tech win the race for medical AI | Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that in... |
| 19.04.2022 | Unlearn raises $50M for clinical trial digital twins and more digital health fundings | Photo: Getty Images/filadendron |
| 26.10.2021 | H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click Therapeutics | STAMFORD, CT – October 26, 2021 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global alternative investment firm with over $45 billion of equity capital under management,*... |
| 25.10.2021 | Click Therapeutics raises $52M, looks to advance digital therapeutics | Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelme... |
| 25.10.2021 | Click Therapeutics lands $52M | Click Therapeutics has raised a $52 million Series B co-led by Accelmed and HIG BioHealth Partners. The New York-based company develops digital prescription medical treatments for patients with chronic pain, autoimmune disorders and other h... |
| 22.10.2021 | Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners | Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed a $52 million upsized Series B financing. The financing round was co-led by new investors H.I.G. Bi... |
| 22.10.2021 | With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more | Another medtech developer's plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year.
Click Therapeutics’ latest... |
| 01.12.2020 | Click Therapeutics Secures $30M | NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc., a leader in Digital Therapeutics solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty ... |
| 07.08.2018 | Which New York City healthcare companies raised the most dough from investors in Q2? | Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million.
Aetion, which focuses on real-world data through the science and analytics platform i... |
| 24.07.2018 | Term Sheet — Tuesday, July 24 | PE BUBBLE?
I read an interesting article titled, “Everything About Private Equity Reeks of Bubble. Party On!” It lays out the concerns of private equity’s record fundraising that’s pushed the industry’s dry powder to more than $1 trillion —... |
| 24.07.2018 | Click Therapeutics Raises $17M in Funding | Click Therapeutics, Inc., a New York-based provider of Digital Therapeutics™ solutions as prescription medical treatments, raised $17m in funding.
The round was led by Sanofi Ventures. Bernard Davitian, SVP and Managing Director of Sanofi V... |
| 23.07.2018 | Sanofi Ventures Leads $17 Million Financing of Click Therapeutics | CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. a leader in Digital Therapeutics solutions as prescription medical treatments, announces a $17 million financing round led by Sanofi Ventures. Click will use this fi... |
| 23.07.2018 | Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform | Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures inve... |
| 08.11.2014 | Funding roundup: Using lasers to change eye color from brown to blue, and more. | Biotech
Abeona Therapeutics – Cleveland, Ohio
$3.6 million in equity raised of a proposed $5 million round
Developing treatments for orphan childhood lysosomal storage disease. Its lead candidates, ABX-A and ABX-B, treat Sanfilippo Type A a... |
| - | Click Therapeutics raises $52M, looks to advance digital therapeutics | Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelme... |
| - | Funding roundup: Using lasers to change eye color from brown to blue, and more. | Each week, many millions are invested into life sciences startups. For example, Stroma Medical – a laser therapy company that claims it can swap your eye color from brown to blue – is in the midst of clinical trials and has raised more cash... |
| - | Click Therapeutics | “A biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Learn more.” |
| - | Click Therapeutics | “We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.” |
| - | Which New York City healthcare companies raised the most dough from investors in Q2? | A new report from New York City Health Business Leaders found that during the second quarter of 2018, investors poured more than $300 million into healthcare startups based in the Big Apple.
The investment update also provides a closer look... |
